Chronic angiotensin II AT1 receptor blockade increases cerebral cortical microvessel density

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 2, 2006, Pages

  Munzenmaier, Diane H ^a   Greene, Andrew S ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Angiotensin receptor blockers; Hypertension; Microvascular growth

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CAPTOPRIL; CD31 ANTIGEN; FUROSEMIDE; LOSARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIURETIC AGENT;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MONITORING; BRAIN BLOOD VESSEL; BRAIN MICROCIRCULATION; CONTROLLED STUDY; FEMORAL ARTERY; FEMORAL VEIN; IMMUNOHISTOCHEMISTRY; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD PRESSURE; BLOOD VESSEL; BRAIN CORTEX; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; MICROCIRCULATION; SPRAGUE DAWLEY RAT; TIME; VASCULARIZATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD VESSELS; CAPTOPRIL; CEREBRAL CORTEX; DIURETICS; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; FUROSEMIDE; LOSARTAN; MALE; MICROCIRCULATION; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 33644865215     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01136.2004     Document Type: Article

References (22)

1. 4 receptor from bovine aortic endothelium with photosensitive analogues of angiotensin IV. Biochemistry 37: 4280-4287, 1998.
2. Dahlöf B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, and Wedel H for the LIFE study group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359: 995-1003, 2002.
3. 1 receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke 30: 2391-2399, 1999.
4. Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, Ishii M, Akagi T, Ikeda H, Matsuishi T, and Imaizumi T. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 112: 67-75, 2003.
5. Forder JP, Munzenmaier DH, and Greene AS. Angiogenic protection from focal ischemia with angiotensin II type 1 receptor blockade in the rat. Am J Physiol Heart Circ Physiol 288: H1989-H1996, 2005.
6. 2 receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ Res 88: 22-29, 2001.
7. Hall KL, Venkateswaran S, Hanesworth JM, Schelling ME, and Harding JW. Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regul Pept 58: 107-115, 1995.
8. Iadecola C and Gorelick PB. Hypertension, angiotensin, and stroke: beyond blood pressure. Stroke 35: 348-350, 2004.
9. 1 antagonist. Stroke 33: 2297-2303, 2002.
10. Munzenmaier DH and Greene AS. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 27: 760-765, 1996.
11. Pawlikowski M and Kunert RJ. Angiotensin IV stimulates the proliferation of rat anterior pituitary cells in vitro. Biochem Biophys Res Commun 232: 292-293, 1997.
12. Rieder MJ, Roman RJ, and Greene AS. Reversal of microvascular rarefaction and reduced renal mass hypertension. Hypertension 30: 120-127, 1997.
13. 1 receptor is present in glioma cells; its blockage reduces the growth of rat glioma. Br J Cancer 85: 1396-1399, 2001.
14. Silvestre JS, Tamarat R, Senbonmatsu T, Icchiki T, Ebrahimian T, Iglarz M, Besnard S, Duriez M, Inagami T, and Lévy BI. Antiangiogenic effect of angiotensin II type 2 receptor in ischemia-induced angiogenesis in mice hindlimb. Circ Res 90: 1072-1079, 2002.
15. 2 receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95: 651-657, 1995.
16. 2 angiotensin II receptors in rat anterior cerebral arteries. Am J Physiol Heart Circ Physiol 261: H667-H670, 1991.
17. Viswanathan M, Tsutsumi K, Correa FJ, and Saavedra JM. Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun 179: 1361-1362, 1991.
18. 2 receptor subtype: an uprising frontier in cardiovascular disease? J Hypertens 21: 1429-1443, 2003.
19. Von Bohlen und Halbach O and Albrecht D. Identification of angiotensin IV binding sites in the mouse brain by a fluorescent binding study. Neuroendocrinology 72: 218-223, 2000.
20. Walther T, Olah L, Harms C, Maul B, Bader M, Hortnagl H, Schultheiss H, and Mies G. Ischemic injury in experimental stroke depends on angiotensin II. FASEB J 16: 169-176, 2002.
21. Wang DH and Prewitt RL. Reduced aortic and arteriolar growth by captopril in normotensive and renal hypertensive rats. Adv Exp Med Biol 308: 217-221, 1991.
22. Wright JW and Harding JW. Important roles for angiotensin II and IV in the brain renin-angiotensin system. Brain Res Rev 25: 96-124, 1997.